Valuation: Doxa AB

Market Cap 452M 47.69M 40.85M 38.23M 34.99M 65.67M 4.56B 66.54M 176M 2.29B 179M 175M 7.58B P/E 2024
-0.38x
P/E 2025 -1.69x
Enterprise Value 1.95B 206M 177M 165M 151M 284M 19.73B 288M 761M 9.91B 774M 757M 32.78B EV / Sales 2024
290x
EV / Sales 2025 102x
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day-1.57%
1 week-1.01%
Current month-3.91%
1 month-4.58%
3 months-22.78%
6 months-11.68%
Current year-21.82%
1 week 0.33
Extreme 0.3325
0.35
1 month 0.33
Extreme 0.3325
0.36
Current year 0.33
Extreme 0.3325
0.46
1 year 0.33
Extreme 0.3325
0.58
3 years 0.32
Extreme 0.32
3.94
5 years 0.32
Extreme 0.32
18.4
10 years 0.32
Extreme 0.32
18.4
Manager TitleAgeSince
Chief Executive Officer 52 09/10/2024
Director of Finance/CFO - 27/04/2026
Director TitleAgeSince
Director/Board Member 67 20/04/2026
Chairman 66 31/12/2023
Director/Board Member 67 28/04/2025
Date Insider Type Main position Quantity % Market Cap.
14/07/26 Buy 100,000 0.0078%
28/02/26 Buy 100,000 0.0078%
01/01/26 Buy

Chairman

1,969,790 0.1532%
Change 5-day change 1-year change 3-year change Capi.($)
-1.57%-1.01%-35.34%-91.03% 47.69M
+2.81%+10.04%+36.46%+47.02% 47.38B
+0.40%+3.45%+12.46%+14.31% 32.18B
+0.19%+0.27%+15.18%+110.21% 27.9B
-0.90%-1.44%-25.44%+61.89% 26.37B
+0.54%+2.81%-7.16%+47.73% 25.36B
+1.63%+5.16%+28.10%+13.48% 21.12B
-1.71%-2.48%-35.93%-62.72% 20.33B
-0.35%+4.60%-1.12%-8.56% 19.68B
-1.33%-1.27%+5.55%+87.27% 19.4B
Average -0.03%+2.05%-0.72%+21.96% 23.98B
Weighted average by Cap. +0.45%+3.18%+6.87%+38.10%

Financials

2024 2025
Net sales 15.5M 1.64M 1.4M 1.31M 1.2M 2.25M 157M 2.28M 6.04M 78.67M 6.15M 6.01M 260M 20.3M 2.14M 1.84M 1.72M 1.57M 2.95M 205M 2.99M 7.92M 103M 8.05M 7.87M 341M
Net income -1.72B -182M -156M -146M -134M -251M -17.41B -254M -672M -8.75B -683M -668M -28.93B -335M -35.42M -30.34M -28.39M -25.99M -48.77M -3.39B -49.41M -131M -1.7B -133M -130M -5.63B
Net Debt 3.56B 376M 322M 302M 276M 518M 36.01B 525M 1.39B 18.09B 1.41B 1.38B 59.82B 1.5B 158M 136M 127M 116M 218M 15.16B 221M 585M 7.62B 595M 582M 25.19B
Logo Doxa AB
Doxa AB is a Sweden-based company which develops products based on bio-active ceramics. The Company develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.
Employees
26
Date Price Change Volume
21/08/26 SEK 0.3440 -1.57% 72,187
20/08/26 SEK 0.3495 +2.95% 1,614,913
19/08/26 SEK 0.3395 -2.86% 454,906
18/08/26 SEK 0.3495 +1.60% 841,481
17/08/26 SEK 0.3440 -1.01% 292,541
  1. Stock Market
  2. Stocks
  3. DOXA Stock